Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895848666> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2895848666 abstract "To evaluate the efficacy of switching treatment from intravitreal ranibizumab to intravitreal aflibercept on the treatment of refractory macular edema secondary to central retinal vein occlusion (CRVO).In this retrospective study; 12 eyes with refractory macular edema secondary to CRVO after multiple monthly repeated intravitreal 0.5mg/0.05mL ranibizumab injections prior to switching therapy to intravitreal 2mg/0.05mL aflibercept, between March 2012 and April 2016 were reviewed. The follow-up time was 12 months. Changes in best-corrected visual acuity (BCVA), central macular thickness (CMT), central retinal volume (CRV) and injection interval between baseline and month 1, 3, 6 and 12 after switching therapy to aflibercept were reviewed and evaluated.Mean baseline CRT decreased from 516±101 mic. to 252±114 mic. at month 12 (P=0.008). Mean baseline CRV decreased from 8.74±2.13 mm3 to 6.82±1.64 mm3 at month 12 (P=0.005). Baseline BCVA improved from 0.73±0.21 to 0.53±0.17 logMAR at month 12 (P=0.004). Mean BCVA gain was two logMar lines (10 letters) at month 12. After switching therapy to aflibercept; the mean injection interval increased significantly from 1.34 months at baseline to 1.86 months at month 12, by an increase of 0.52 months (P=0.02).Intravitreal aflibercept is evaluated to be presenting significant visual and anatomical improvements in patients with persistent macular edema due to CRVO despite previous intravitreal ranibizumab." @default.
- W2895848666 created "2018-10-26" @default.
- W2895848666 creator A5021621006 @default.
- W2895848666 creator A5040079229 @default.
- W2895848666 creator A5044643977 @default.
- W2895848666 creator A5060775455 @default.
- W2895848666 creator A5069077004 @default.
- W2895848666 creator A5076110312 @default.
- W2895848666 date "2018-11-01" @default.
- W2895848666 modified "2023-09-25" @default.
- W2895848666 title "Effect of aflibercept on persistent macular edema secondary to central retinal vein occlusion" @default.
- W2895848666 cites W1565832645 @default.
- W2895848666 cites W1971399814 @default.
- W2895848666 cites W1976154023 @default.
- W2895848666 cites W2021225304 @default.
- W2895848666 cites W2049825589 @default.
- W2895848666 cites W2052204551 @default.
- W2895848666 cites W2068742492 @default.
- W2895848666 cites W2075780935 @default.
- W2895848666 cites W2093044616 @default.
- W2895848666 cites W2095491446 @default.
- W2895848666 cites W2103827117 @default.
- W2895848666 cites W2106466837 @default.
- W2895848666 cites W2114441193 @default.
- W2895848666 cites W2128701654 @default.
- W2895848666 cites W2132849987 @default.
- W2895848666 cites W2143874967 @default.
- W2895848666 cites W2151081020 @default.
- W2895848666 cites W2163616867 @default.
- W2895848666 cites W2166985747 @default.
- W2895848666 cites W2172223254 @default.
- W2895848666 cites W2177245277 @default.
- W2895848666 cites W2323996518 @default.
- W2895848666 cites W2510433706 @default.
- W2895848666 doi "https://doi.org/10.1016/j.jfo.2018.01.024" @default.
- W2895848666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30361176" @default.
- W2895848666 hasPublicationYear "2018" @default.
- W2895848666 type Work @default.
- W2895848666 sameAs 2895848666 @default.
- W2895848666 citedByCount "1" @default.
- W2895848666 countsByYear W28958486662023 @default.
- W2895848666 crossrefType "journal-article" @default.
- W2895848666 hasAuthorship W2895848666A5021621006 @default.
- W2895848666 hasAuthorship W2895848666A5040079229 @default.
- W2895848666 hasAuthorship W2895848666A5044643977 @default.
- W2895848666 hasAuthorship W2895848666A5060775455 @default.
- W2895848666 hasAuthorship W2895848666A5069077004 @default.
- W2895848666 hasAuthorship W2895848666A5076110312 @default.
- W2895848666 hasConcept C118487528 @default.
- W2895848666 hasConcept C141071460 @default.
- W2895848666 hasConcept C2776694085 @default.
- W2895848666 hasConcept C2777802072 @default.
- W2895848666 hasConcept C2778257484 @default.
- W2895848666 hasConcept C2778749236 @default.
- W2895848666 hasConcept C2778844676 @default.
- W2895848666 hasConcept C2780347916 @default.
- W2895848666 hasConcept C2780827179 @default.
- W2895848666 hasConcept C2781100027 @default.
- W2895848666 hasConcept C71924100 @default.
- W2895848666 hasConceptScore W2895848666C118487528 @default.
- W2895848666 hasConceptScore W2895848666C141071460 @default.
- W2895848666 hasConceptScore W2895848666C2776694085 @default.
- W2895848666 hasConceptScore W2895848666C2777802072 @default.
- W2895848666 hasConceptScore W2895848666C2778257484 @default.
- W2895848666 hasConceptScore W2895848666C2778749236 @default.
- W2895848666 hasConceptScore W2895848666C2778844676 @default.
- W2895848666 hasConceptScore W2895848666C2780347916 @default.
- W2895848666 hasConceptScore W2895848666C2780827179 @default.
- W2895848666 hasConceptScore W2895848666C2781100027 @default.
- W2895848666 hasConceptScore W2895848666C71924100 @default.
- W2895848666 hasLocation W28958486661 @default.
- W2895848666 hasLocation W28958486662 @default.
- W2895848666 hasOpenAccess W2895848666 @default.
- W2895848666 hasPrimaryLocation W28958486661 @default.
- W2895848666 hasRelatedWork W2321859266 @default.
- W2895848666 hasRelatedWork W2518914114 @default.
- W2895848666 hasRelatedWork W2521155275 @default.
- W2895848666 hasRelatedWork W2578851731 @default.
- W2895848666 hasRelatedWork W2588621177 @default.
- W2895848666 hasRelatedWork W2606213351 @default.
- W2895848666 hasRelatedWork W2805081295 @default.
- W2895848666 hasRelatedWork W2971306116 @default.
- W2895848666 hasRelatedWork W3131125541 @default.
- W2895848666 hasRelatedWork W4205243730 @default.
- W2895848666 isParatext "false" @default.
- W2895848666 isRetracted "false" @default.
- W2895848666 magId "2895848666" @default.
- W2895848666 workType "article" @default.